[en] Regeneration/repair and protection of auditory hair cells and auditory neurons is an exciting, rapidly evolving field. Simultaneous developments in the fields of otobiology and surgical otology have led to new and exciting possibilities in inner ear medicine and surgery; specifically, the treatment or prevention of a variety of types of hearing losses in the foreseeable future. Sensorineural hearing loss in humans is commonly associated with a loss of auditory hair cells. It has been generally accepted that hearing loss resulting from hair cell damage is irreversible because the human ear has been considered to be incapable of regenerating or repairing these sensory elements following severe injury. An organ of Corti explant study has shown that it is possible to initiate the regeneration/repair of mammalian hair cells. In this study, ototoxin-damaged organ of Corti explants from juvenile rats were treated with a combination of retinoic acid (10-8M) and fetal calf serum (10%). TGF-alpha has been identified as a growth factor capable of evoking auditory hair cell regeneration/repair in ototoxin-damaged organ of Corti explants. Preliminary in vitro experiments with juvenile rat organ of Corti explants and in vivo studies in the cochleae of adult guinea pigs indicate that pretreatment followed by continuous treatment of the inner ear with a combination of retinoic acid and TGF-alpha can protect the auditory hair cells from the ototoxic effects of aminoglycosides. Because the integrity of spiral ganglion neurons is also essential for normal auditory function, there is a parallel series of in vitro and in vivo studies of the effects of neurotrophic factors on the survival of auditory neurons and the regeneration of injured neuronal processes. Clinical studies have demonstrated that it is now possible to perform surgeries on the inner ear, i.e., partial or total labyrinthectomies, and maintain hearing. The field of cochlear implantation has also provided insights into both the short- and long-term effects of cochlear fenestration on inner ear function. Administration of growth factors to the inner ears of animals is now possible with the use of implanted catheters and miniature infusion pumps. These advances suggest that localized application of drugs to the human inner ear may be feasible. The aim of this paper has been to provide an overview of advances in the study of the biology of auditory hair cells and auditory neurons, as well as recent relevant surgical advances. Taken together, these advances in otobiology and surgery will, in the future, be combined to devise new and innovative treatments for inner ear disorders.
Disciplines :
Otolaryngology
Author, co-author :
Feghali, J. G.
Lefèbvre, Philippe ; Université de Liège > Département des sciences cliniques > Oto-rhino-laryngologie et audiophonologie
Corwin JT. Postembryonic production and aging of inner ear hair cells in sharks. J Comp Neurol 1981;201:541-53.
Corwin JT. Postembryonic growth of the macula neglecta auditory detector in the ray, Raja clavata: Continual increases in hair cell number, neural convergence, and physiological sensitivity. J Comp Neurol 1983; 217:345-56.
Corwin JT. Perpetual production of hair cells and maturational changes in hair cell ultrastructure accompany postembryonic growth in an amphibian ear. Proc Natl Acad Sci USA 1985;82(11):3911-15.
Ruben RJ. Development of the inner ear in the mouse: A radioautographic study of terminal mitoses. Acta Otolaryngol (Stockh) 1967;220(Suppl):1-44.
Cruz RM, Lambert PR, Rubel EW. Light microscopic evidence of hair cell regeneration after gentamicin toxicity in chick cochlea. Arch Otolaryngol Head Neck Surg 1987;113:1058-62.
Cotanche DA. Regeneration of hair cell stereociliary bundles in the chick cochlea following severe acoustic trauma. Hear Res 1987; 30:181-96.
Corwin JT, Cotanche DA. Regeneration of sensory hair cells after acoustic trauma. Science 1988;240:1772-4.
Ryals BM, Rubel EW. Hair cell regeneration after acoustic trauma in adult Coturnix quail. Science 1988;240:1774-6.
Tucci DL, Rubel EW. Physiologic status of regenerated hair cells in the avian inner ear following aminoglycoside ototoxicity. Otolaryngol Head Neck Surg 1990;103:443-50.
Represa J, Sanchez A, Miner C, et al. Retinoic acid modulation of the early development of the inner ear is associated with the control of c-fos expression. Development 1990;110:1081-90.
Kelley MW, Xu M-M, Wagner MA, et al. The developing organ of Corti contains retinoic acid and forms supernumerary hair cells in response to exogenous retinoic acid in culture. Development 1993; 119:1041-53.
Sobkowicz HM, August BK, Slapnick SM. Epithelial repair following mechanical injury of the developing organ of Corti in culture: An electron microscopic and autoradiographic study. Exper Neurol 1992;115:44-9.
Forge A, Corwin JT, Nevill G. Ultrastructural evidence for hair cell regeneration in the mammalian inner ear. Science 1993;259:1616-19.
Fee WE. Aminoglycoside toxicity in the human. Laryngoscope 1980;90(Suppl24):1-19.
Winkel O, Hansen M, Kaaber K, et al. A prospective study of gentamicin ototoxicity. Acta Otolaryngol (Stockh) 1978;86:212-16.
Lefebvre PP, Malgrange B, Staecker H, et al. Retinoic acid stimulates regeneration of mammalian auditory hair cells. Science 1993; 260:692-5.
Staecker H, Lefebvre PP, Malgrange B, et al. Technical comments - Regeneration and mammalian auditory hair cells. Science 1995;267:709-11.
Lambert PR. Inner ear hair cell regeneration in a mammal: Identification of a triggering factor. Laryngoscope 1994;104:701-18.
Kopelman J, Budnick AS, Sessions RB, et al. Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing. Laryngoscope 1988;98:858-64.
Malgrange B, Lefebvre PP, Baron H, et al. Transforming growth factor alpha (TGFα) acts with retinoic acid to protect auditory hair cells from aminoglycoside induced ototoxicity [abstract]. Proceedings of the 17th Annual Midwinter Meeting, Association for Research in Otolaryngology; 1994 Feb 6-10; St. Petersburg Beach, FL:138.
Brown JN, Miller JM, Altschuler RA, et al. Miniosmotic pump implant for chronic infusion of drugs in the inner ear. Hear Res 1993;70:167-72.
Schweitzer VG, Dolan DF, Davidson T, et al. Amelioration of cisplatin induced ototoxicity by fosfomycin. Laryngoscope 1986;96:948-58.
Gandara D, Weibe VJ, Perez EA, et al. Cisplatin rescue therapy: Experience with sodium thiosulfate, WR2721 and diethyldithiocarbamate. Oncol Hematol 1990;10:353-65.
Schweitzer VG Cisplatin-induced ototoxicity: The effects of pigmentation and inhibitory agents. Laryngoscope 1993; 103:1-52.
Hamers FPT, Klis SFL, Gispen WH, et al. Application of a neuroprotective ACTH(4-9) analog to affect cisplatin ototoxicity: An electrocochleographic study in guinea pigs. Eur Arch Otorhinolaryngol 1994;251:23-9.
Apfel SC, Arezzo JC, Brownlee M, et al. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 1994;634:7-12.
Apfel SC, Arezzo JC, Lipson LA, et al. Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 1992;31:76-80.
Ernfors P, Van De Water TR, Loring J, et al. Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 1995;14:1153-64
Lefebvre PP, Malgrange B, Staecker H, et al. Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. NeuroReport 1994;5:865-8.
Staecker H, Kopke R, Lefebvre PP, et al. The effects of neurotrophins on adult auditory neurons in vitro and in vivo [abstract 705]. Proceedings of the 18th Annual Midwinter Meeting, Assoc Res Otolaryngol 1995:177.
Parnes LS, McClure JA. Postenor semicircular canal occlusion in the normal hearing ear. Otolaryngol Head Neck Surg 1991;104:52-7.
McElveen JT Jr, Wilkins RH, Molter DW, et al. Hearing preservation using the modified translabyrinthine approach. Otolaryngol Head Neck Surg 1993;108:671-9.
Hirsch BE, Cass SP, Sekhar LN, et al. Translabyrinthine approach to skull base tumors with hearing preservation. Am J Otol 1993;14:533-43.
Linthicum FH Jr, Fayad J, Otto SR, et al. Cochlear implant histopathology. Am J Otol 1991;12:245-311.
Balkany T, Hodges AV, Whitehead M, et al. Cochlear endoscopy with preservation of hearing in guinea pigs. Otolaryngol Head Neck Surg 1994;111:439-45.
Zine A, de Ribaupierre F. Replacement of mammalian auditory hair cells. NeuroReport 1997; 9:263-8.
Priuska EM, Schacht J. Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem Pharmacol 1995; 50(11):1749-52.
Song BB, Schacht J. Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo. Hear Res 1996; 94(1-2):87-93.
Song BB, Anderson DJ, Schacht J. Protection from gentamicin ototoxicity by iron chelators in guinea pig in vivo. J Pharmacol Exp Therap 1997; 282(1):369-77.
Gabaizadeh R, Staecker H, Liu W, et al. Protection of both auditory hair cells and auditory neurons from cisplatin induced damage. Acta Otolaryngol (Stockh) 1997; 117:232-8.
Kopke RD, Liu W, Gabaizadeh R, et al. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am J Otol 1997; 18:559-71.
Campbell KCM, Rybak LP, Meech RP, et al. D-methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 1996; 102:90-8.
Rho MB, Reser DH, Dewan D. Structural evidence for protection from cisplatin ototoxicity by both D- and L-methionine in vivo [abstract 202]. Proceedings of the 21st Midwinter Meeting, Assoc Res Otolaryngol; 1998 Feb 14-19; St. Petersburg, Florida.
Reser DH, Rho MB, Dewan, et al. Physiological evidence for protection from cisplatin ototoxicity by D- and L-methionine in vivo [abstract 203]. Proceedings of the 21st Midwinter Meeting, Assoc Res Otolaryngol, 1998 Feb 14-19; St. Petersburg, Florida.
Campbell KCM, Meech RP, Rybak LP. D-methionine provides protection against cisplatin damage in the rat stria vascularis: A semi-quantitative analysis [abstract 537]. Proceedings of the 21st Midwinter Meeting, Assoc Res Otolaryngol; 1998 Feb 14-19; St. Petersburg, Florida.
Korver KD, Rybak LP, Whitworth CA, et al. Round window application of D-methionine provides cisplatin otoprotection [abstract 536]. Proceedings of the 21st Midwinter Meeting, Assoc Res Otolaryngol; 1998 Feb 14-19; St. Petersburg, Florida
Staecker H, Kopke R, Malgrange B, et al. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. NeuroReport 1996; 7:889-94.
Emfors P, Duan ML, ElShamy WM, et al. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nature Med 1996; 2(4):463-7.
Staecker H, Gabaizadeh R, Federoff H, et al. BDNF gene therapy prevents spiral ganglion degeneration following hair cell loss. Otolaryngol Head Neck Surg 1998. In press.
Gabaizadeh R, Staecker H, Liu W, et al. BDNF protection of auditory neurons from cisplatin involves changes in intracellular levels of both reactive oxygen species and glutathione. Mol Brain Res 1997; 50:71-8.
